Latest News on UTMD

Financial News Based On Company


Advertisement
Advertisement

Utah Medical Products, Inc. (UTMD) Raises Quarterly Dividend 1.6% to $0.315

https://www.tradingview.com/news/tradingview:140bd3556b36a:0-utah-medical-products-inc-utmd-raises-quarterly-dividend-1-6-to-0-315/
Utah Medical Products, Inc. (UTMD) has announced a 1.6% increase in its quarterly cash dividend, raising it to $0.315 per share. The dividend is scheduled for payment on January 5, 2027, to shareholders of record as of December 17, 2026. An AI Analyst noted this as a modest positive for income-focused investors, requiring further capital allocation updates for broader catalytic impact.

Utah Medical Products Raises Quarterly Dividend 1.6% to $0.315 per Share

https://www.tradingview.com/news/tradingview:bae05c7b91771:0-utah-medical-products-raises-quarterly-dividend-1-6-to-0-315-per-share/
Utah Medical Products (UTMD) has announced a 1.6% increase in its regular quarterly cash dividend, raising it to $0.315 per share. The dividend is scheduled for payment on January 5, 2027, to shareholders of record as of December 17, 2026. This announcement was made on November 3, 2026, as per an SEC filing.

Chairman of Utah Medical Products Kevin Cornwell Buys More Stock

https://simplywall.st/stocks/us/healthcare/nasdaq-utmd/utah-medical-products/news/chairman-of-utah-medical-products-kevin-cornwell-buys-more-s
The Chairman of Utah Medical Products, Kevin Cornwell, recently purchased US$67k worth of company stock at US$66.75 per share, representing the largest insider purchase in the last year. This transaction, though a minuscule percentage increase in his overall shareholding, indicates confidence in the company's future from an insider perspective, especially since the purchase was made close to the current stock price of US$70.02. Insiders collectively own about 7.2% of the company's shares.

Utah Medical Products, Inc. (UTMD) Raises Quarterly Dividend 1.6%

https://www.tradingview.com/news/tradingview:140bd3556b36a:0-utah-medical-products-inc-utmd-raises-quarterly-dividend-1-6/
Utah Medical Products, Inc. (UTMD) has announced a 1.6% increase in its quarterly cash dividend, raising it to $0.315 per share. The dividend is scheduled for payment on January 5, 2027, to shareholders of record as of December 17, 2026. This modest increase is noted as a recurring capital return update for income-focused investors.

(UTMD) Price Dynamics and Execution-Aware Positioning

https://news.stocktradersdaily.com/news_release/81/UTMD_Price_Dynamics_and_Execution-Aware_Positioning_110426032001_1793780401.html
This article provides an AI-driven analysis of Utah Medical Products Inc. (NASDAQ: UTMD), highlighting weak near and mid-term sentiment despite a long-term positive outlook. It presents three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis to guide traders on entry and exit points and risk parameters. The analysis indicates elevated downside risk due to a lack of additional long-term support signals.
Advertisement

Utah Medical Products (UTMD) Declares $0.315 Quarterly Dividend; 1.8% Yield

https://www.streetinsider.com/Dividends/Utah+Medical+Products+%28UTMD%29+Declares+%240.315+Quarterly+Dividend%3B+1.8%25+Yield/27279059.html
Utah Medical Products (NASDAQ: UTMD) has announced a quarterly dividend of $0.315 per share, amounting to $1.26 annually. This dividend represents an annual yield of 1.8 percent and is payable on January 5, 2027, to shareholders of record as of December 17, 2026, with an ex-dividend date of December 16, 2026.

Form 8K Utah Medical Products Inc For: 3 November By Investing.com

https://uk.investing.com/news/stock-market-news/form-8k-utah-medical-products-inc-for-3-november-93CH-4953596
This article reports that Utah Medical Products Inc. filed a Form 8K on November 3, 2026. The filing is related to the company's financial activities and is available through Investing.com, a financial markets news and data platform.

Utah Medical Products raises quarterly dividend by 1.6%

https://ca.investing.com/news/stock-market-news/utah-medical-products-raises-quarterly-dividend-by-16-93CH-4926102
Utah Medical Products Inc. (Nasdaq: UTMD) announced a 1.6% increase in its quarterly cash dividend, raising it to $0.315 per share of common stock. The dividend will be paid on January 5, 2027, to shareholders of record as of December 17, 2026. The company specializes in developing, manufacturing, and marketing disposable and reusable medical devices for women's and babies' healthcare.

Utah Medical Products Raises Quarterly Dividend 1.6% to $0.315

https://www.tokenpost.com/news/business/47988
Utah Medical Products, Inc. has increased its quarterly dividend by 1.6% to $0.315 per share, up from $0.310. The payment is scheduled for January 5, with December 17 designated as both the record and ex-dividend date. The company, which specializes in medical devices for women's and babies' health, reported a 12.1% drop in third-quarter sales but a 6.8% rise in diluted GAAP earnings per share.

Utah Medical Products, Inc. Increases Quarterly Dividend

https://www.tradingview.com/news/acceswire:7e2d4b9bf094b:0-utah-medical-products-inc-increases-quarterly-dividend/
Utah Medical Products, Inc. (UTMD) announced that its Board of Directors has approved a 1.6% increase in its quarterly cash dividend, raising it to thirty-one and one-half cents ($.315) per share. The dividend is payable on January 5, 2027, to stockholders of record on December 17, 2026. The company specializes in developing, manufacturing, and marketing specialty medical devices, particularly for women and babies.
Advertisement

A 31.5-cent-per-share quarterly dividend from Utah Medical Products is due Jan. 5.

https://www.stocktitan.net/news/UTMD/utah-medical-products-inc-increases-quarterly-wucxb6ph5wob.html
Utah Medical Products (Nasdaq: UTMD) has announced a 1.6% increase in its quarterly cash dividend, raising it to $0.315 per common share. This dividend is payable on January 5, 2027, to shareholders of record as of December 17, 2026. The company specializes in developing, manufacturing, and marketing medical devices, particularly for women's and infant care.

Utah Medical Products, Inc. (UTM.F) Seasonal Returns Chart - Yahoo Finance

https://ca.finance.yahoo.com/quote/UTM.F/seasonality/
This Yahoo Finance article provides a seasonal returns chart for Utah Medical Products, Inc. (UTM.F), displaying the average monthly price return from 2020 to 2026. The stock is listed on the Frankfurt exchange with a delayed quote, showing a current price of 59.50 EUR, up 3.48%. The page includes various market data and research options related to the company.

Kevin L Cornwell Of Utah Medical Products Shows Optimism, Buys $66K In Stock

https://www.benzinga.com/news/26/10/62744094/kevin-l-cornwell-utah-medical-products-shows-optimism-buys-66k-stock
Kevin L Cornwell, Chairman at Utah Medical Products (NASDAQ: UTMD), recently purchased 1,000 shares of the company's stock for $66,750, indicating optimism about the company's future. Utah Medical Products, which develops and distributes proprietary medical devices for hospital use, showed a 1.08% revenue growth as of September 30, 2026, and maintains a high gross margin of 56.14%. Despite a lower-than-average EPS and market capitalization, its P/E and EV/EBITDA ratios suggest it might be undervalued.

A CEO buys 1,000 shares of Utah Medical Products (UTMD) at $66.75 each.

https://www.stocktitan.net/sec-filings/UTMD/form-4-utah-medical-products-inc-insider-trading-activity-f220186a43c9.html
Kevin L. Cornwell, Chairman and CEO of Utah Medical Products Inc. (UTMD), indirectly purchased 1,000 common shares at $66.75 per share on October 29, 2026. Following this transaction, his total reported holdings increased to 189,472 shares, which are held across his IRA, the Cornwell Bypass Trust, and the Cornwell Survivor's Trust. This insider trade was filed as a Form 4 with the SEC.

Utah Medical Products, Inc. Reports Results of Tender Offer

https://www.tradingview.com/news/acceswire:444951aa5094b:0-utah-medical-products-inc-reports-results-of-tender-offer/
Utah Medical Products, Inc. (UTMD) announced the results of its tender offer, which expired on October 27, 2026. The company purchased 322,215 shares of its common stock at $75.00 per share, totaling over $24 million. After the tender offer, 2,854,566 shares remain outstanding, with additional costs for administration, filing fees, and a federal excise tax on repurchases.
Advertisement

At $75 a share, Utah Medical Products (UTMD) completes its tender offer.

https://www.stocktitan.net/sec-filings/UTMD/sc-to-i-a-utah-medical-products-inc-amended-issuer-tender-offer-549f1bc4eb23.html
Utah Medical Products, Inc. (UTMD) has successfully completed its issuer tender offer, repurchasing 327,740 shares of its common stock at $75.00 per share, totaling $24,580,500. The offer, which expired on October 27, 2026, resulted in an effective cost of $75.35 per share after administrative and SEC filing fees. Following the repurchase, the company reported 2,849,041 shares outstanding as of October 29, 2026, and will also incur a 1% federal excise tax on the share repurchases.

Utah Medical Products, Inc. Reports Corrected Results of Tender Offer

https://www.tradingview.com/news/acceswire:f43336731094b:0-utah-medical-products-inc-reports-corrected-results-of-tender-offer/
Utah Medical Products, Inc. announced corrected results for its tender offer, which expired on October 27, 2026. The company purchased 327,740 shares at $75.00 per share, totaling $24,580,500. After the purchase, 2,849,041 shares remain outstanding, with additional costs for administration and SEC filing.

A medical-device maker spent $24.6 million buying back its own shares.

https://www.stocktitan.net/news/UTMD/utah-medical-products-inc-reports-corrected-results-of-tender-3y4zfxeb82j6.html
Utah Medical Products (Nasdaq:UTMD) announced the corrected results of its tender offer, which expired on October 27, 2026. The company repurchased 327,740 common shares at $75.00 per share, totaling $24,580,500. This tender offer was for a maximum of 650,000 shares, and the effective cost per share was $75.35, with additional administration fees, SEC filing fees, and a 1% federal excise tax on share repurchases.

Utah Medical Products, Inc. (UTMD) Buys 327,740 Shares at $75 in Tender

https://www.tradingview.com/news/tradingview:7ff4fdb4cc862:0-utah-medical-products-inc-utmd-buys-327-740-shares-at-75-in-tender/
Utah Medical Products, Inc. (UTMD) recently purchased 327,740 shares at $75.00 per share, totaling $24.58 million, via a tender offer. This transaction, which includes an effective cost of $75.35 per share after fees and a 1% federal excise tax, reduces the company's outstanding shares to 2,849,041. An AI analyst notes that this move signals capital return and balance sheet deployment, potentially boosting EPS and impacting valuation.

Utah Medical Products, Inc. Reports Results of Tender Offer

https://www.corsicanadailysun.com/national/utah-medical-products-inc-reports-results-of-tender-offer/article_52166366-d5fd-549e-99e5-2ff74438191b.html
Utah Medical Products, Inc. announced the results of its tender offer, which expired on Tuesday, October 27. The company successfully purchased 322,215 shares of its common stock at $75.00 per share, totaling $24,166,125. Following the offer, 2,854,566 shares remain outstanding, including recent employee option exercises.
Advertisement

The $75-per-share offer had an effective cost of $75.36 per share for Utah Medical Products.

https://www.stocktitan.net/news/UTMD/utah-medical-products-inc-reports-results-of-tender-qxk2pity8lwt.html
Utah Medical Products (UTMD) completed a tender offer, purchasing 322,215 common shares at $75.00 per share, totaling $24,166,125. The effective cost per share was $75.36 due to administration and SEC filing fees, with an additional 1% federal excise tax to be levied. The company's outstanding shares now stand at 2,854,566.

Utah Medical Products, Inc. (UTMD) Buys 322,215 Shares at $75 in Tender

https://www.tradingview.com/news/tradingview:69182780ad382:0-utah-medical-products-inc-utmd-buys-322-215-shares-at-75-in-tender/
Utah Medical Products, Inc. (UTMD) has completed a tender offer, purchasing 322,215 shares at $75.00 each, totaling $24.17 million. This transaction reduces the shares outstanding to 2,854,566, with an effective cost per share of $75.36 after fees and a 1% excise tax. The tender offer was undersubscribed, as 650,000 shares were offered but only 322,215 were tendered.

Utah Medical Products, Inc. Reports Results of Tender Offer

https://www.theglobeandmail.com/investing/markets/stocks/UTMD-Q/pressreleases/8527584/utah-medical-products-inc-reports-results-of-tender-offer/
Utah Medical Products, Inc. (NASDAQ:UTMD) has announced the results of its tender offer, which expired on Tuesday, October 27. The company purchased 322,215 shares of its common stock at $75.00 per share, totaling $24,166,125. Following the offer, 2,854,566 shares remain outstanding, with additional costs for administration fees and an upcoming federal excise tax on share repurchases.

Utah Medical Products stock: Revenue drop of 12.10 percent hits Utah Medical Products stock

https://www.ad-hoc-news.de/boerse/news/nebenwerte/utah-medical-products-stock-revenue-drop-of-12-10-percent-hits-utah-medical-products-stock/70401513
Utah Medical Products (UTMD) reported a 12.10 percent decline in third-quarter sales to USD 8.62 million, although net income increased by 5.90 percent to USD 2.79 million. Despite the revenue drop, operating income rose by 7.00 percent, improving the operating margin. The company's tender offer to repurchase up to 650,000 shares at USD 75.00 is set to expire on October 27, 2026.

Utah Medical Products stock: Revenue drop of 12.10 percent hits Utah Medical Products stock

https://www.ad-hoc-news.de/boerse/news/nebenwerte/utah-medical-products-stock-revenue-drop-of-12-10-percent-hits-utah/70401513
Utah Medical Products reported a 12.10% drop in third-quarter sales to USD 8.62 million, although net income increased by 5.90% to USD 2.79 million. The company's operating income rose by 7.00%, with the operating margin improving to 32.40% due to lower litigation and intangible-asset amortization expenses. Utah Medical Products continues its capital return plan, with a tender offer for up to 650,000 shares expiring on October 27, 2026.
Advertisement

Utah Medical Products, Inc. (UTMD) Q3 Rev Down 12%, EPS Up 7%

https://www.tradingview.com/news/tradingview:588a3cad49ad8:0-utah-medical-products-inc-utmd-q3-rev-down-12-eps-up-7/
Utah Medical Products, Inc. (UTMD) reported a Q3 2026 revenue of $8.62M, down 12% year-over-year, while diluted EPS increased by 6.8% to $0.876. Despite revenue pressure from lost sales in China BPM and PendoTECH, net income rose 5.9% and operating margin improved to 32.4%, driven by lower amortization, litigation, and tax rates. The company forecasts a full-year 2026 sales decline of approximately 7%, anticipating stabilization in Q4.

Utah Medical Products, Inc. Estimates – NASDAQ:UTMD

https://www.tradingview.com/symbols/NASDAQ-UTMD/financials-estimates/
The article provides an overview of Utah Medical Products, Inc. (NASDAQ: UTMD) financial data and analyst estimates available on TradingView. It highlights sections for exploring reported financial data across income statements, balance sheets, cash flow statements, and valuation metrics, allowing users to compare actual results with average, high, and low estimates and visualize trends. The content explicitly states that it is not investment advice and encourages users to conduct their own research.

Utah Medical Products Q3 EPS Rises 6.8% as Sales Fall 12.1%

https://www.tokenpost.com/news/business/39232
Utah Medical Products (Nasdaq: UTMD) reported a 6.8% increase in diluted GAAP earnings per share to $0.876 for the third quarter of 2026, despite a 12.1% drop in sales to $8.621 million. Net income rose 5.9% to $2.787 million, primarily due to lower litigation and intangible-asset amortization expenses. The company's acquisition of Orion Medical Supplies contributed $619,000 in sales, offsetting declines in other areas.

Utah Medical Products, Inc. Estimates – SWB:UTM

https://www.tradingview.com/symbols/SWB-UTM/financials-estimates/
This article provides an overview of Utah Medical Products, Inc. (UTM) financial estimates available on TradingView, covering reported financial data and analyst estimates across various financial statements and valuation metrics. It allows users to compare actual results with average, high, and low estimates, and visualize trends over time for the Stuttgart Stock Exchange-listed company. The content explicitly states it is not investment advice and encourages users to conduct their own research.

Form 8K Utah Medical Products Inc For: 22 October By Investing.com

https://ca.investing.com/news/stock-market-news/form-8k-utah-medical-products-inc-for-22-october-93CH-4897674
This article announces that Utah Medical Products Inc. filed a Form 8K on October 22, 2026. The filing is an important regulatory disclosure for the company. The brief mention includes the company's stock symbol, UTMD.
Advertisement

Utah Medical Products Q3 Net Income Rises 6%; Nine-Month Revenue Falls 12%

https://www.tradingview.com/news/tradingview:f25615dfce304:0-utah-medical-products-q3-net-income-rises-6-nine-month-revenue-falls-12/
Utah Medical Products reported a 12.1% year-over-year revenue decline to $8.621 million in Q3 2026, while net income increased 5.9% to $2.787 million. For the first nine months, revenue fell 12.2% to $25.873 million and net income decreased 7.4% to $8.077 million, primarily due to lost customers, lower Filshie Clip System sales, and weaker neonatal device sales. The company projects a full-year 2026 sales decline close to 7%.

A UK acquisition added $619,000 in quarterly sales as Utah Medical Products' revenue fell 12.1%.

https://www.stocktitan.net/news/UTMD/utmd-reports-financial-performance-for-third-calendar-quarter-and-8ibi4rmtbtj5.html
Utah Medical Products (UTMD) reported an 12.1% decline in third-quarter 2026 revenue to $8.621 million, primarily due to lost major customers and decreased Filshie device sales, though net income and EPS increased by 6% and 7% respectively, supported by lower litigation expenses. A strategic acquisition of Orion Medical Supplies in the UK contributed $619,000 in quarterly sales, partly offsetting the overall revenue drop. The company projects a full-year sales decline of approximately 7% amidst ongoing market uncertainties.

Utah Medical Products stock trades at EUR 67.00 before quarterly results

https://www.ad-hoc-news.de/boerse/news/nebenwerte/utah-medical-products-stock-trades-at-eur-67-00-before-quarterly-results/70373411
Utah Medical Products' stock is trading at EUR 67.00 as the company approaches key dates for shareholders. The tender offer for 650,000 shares at USD 75.00 has been extended to October 27, 2026, coinciding with the release of third-quarter results on October 22, 2026. This period is critical for shareholders to assess the company's performance, especially after a 12.3% drop in first-half 2026 revenue.

Utah Medical Products extends tender offer for Utah Medical Products stock

https://www.ad-hoc-news.de/boerse/news/nebenwerte/utah-medical-products-extends-tender-offer-for-utah-medical-products-stock/70328930
Utah Medical Products (UTMD) has extended its tender offer to buy back up to 650,000 shares at $75.00 per share, with the new deadline being October 27, 2026. This decision follows a weaker first half of 2026, where revenue fell 12.30 percent. Shareholders will have the company's third-quarter 2026 results before the offer expires.

Liquidity Mapping Around (UTMD) Price Events

https://news.stocktradersdaily.com/news_release/21/Liquidity_Mapping_Around_UTMD_Price_Events_101426062802_1792016882.html
This article provides an AI-driven analysis of Utah Medical Products Inc. (NASDAQ: UTMD), highlighting a strong near-term sentiment that could lead to a long-term positive bias. It identifies a mid-channel oscillation pattern and an exceptional 21.6:1 risk-reward setup targeting a 6.1% gain versus 0.3% risk. The analysis also presents institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis and support/resistance levels.
Advertisement

UTMD Trades at a Premium to the Industry: How to Play the Stock?

https://fr.tradingview.com/news/zacks:5607f0b95094b:0-utmd-trades-at-a-premium-to-the-industry-how-to-play-the-stock/
Utah Medical Products, Inc. (UTMD) is trading at a premium valuation compared to its industry peers, reflecting investor confidence despite recent revenue declines. The company has strategic tailwinds including a recent acquisition and strong financial position, but faces headwinds from falling revenues and rising costs. While its fundamentals suggest holding for long-term investors, new investors might wait for a better entry point.

Utah Medical Products stock trades at EUR 66.00 ahead of results

https://www.ad-hoc-news.de/boerse/news/nebenwerte/utah-medical-products-stock-trades-at-eur-66-00-ahead-of-results/70265761
Utah Medical Products (UTMD) stock was trading at EUR 66.00, up 0.76% from its prior close, ahead of its Q3 2026 earnings report scheduled for October 22, 2026. The upcoming report will be crucial as the company reported a 12% drop in first-half 2026 sales and a 13% decline in net profits compared to the same period in 2025. The company specializes in medical devices for labor and delivery, neonatal intensive care, and women's health.

Utah Medical Products extends tender offer for Utah Medical Products stock

https://www.ad-hoc-news.de/boerse/news/nebenwerte/utah-medical-products-extends-tender-offer-for-utah-medical-products-stock/70247091
Utah Medical Products (UTMD) has extended its tender offer to buy back up to 650,000 common shares at USD 75.00 each, moving the deadline to October 27, 2026. This extension allows shareholders more time to consider the company's Q3 2026 results, which are scheduled for October 22, 2026, especially in light of a 12% decline in first-half 2026 sales and a 13% drop in net profit compared to the previous year. The offer price represents a 17% premium over the 12-month average daily closing price.

Utah Medical Products, Inc. Extends Tender Offer

https://ca.finance.yahoo.com/news/utah-medical-products-inc-extends-123000509.html
Utah Medical Products, Inc. (Nasdaq:UTMD) has extended its tender offer to purchase up to 650,000 shares of its common stock at $75.00 per share. The new expiration date is Tuesday, October 27, 2026, at 5:00 p.m. New York City time, allowing stockholders to consider the company's 3Q 2026 financial results scheduled for announcement on October 22. All other conditions of the offer remain unchanged.

Utah Medical extends tender offer deadline to October 27

https://www.investing.com/news/company-news/utah-medical-extends-tender-offer-deadline-to-october-27-93CH-4932116
Utah Medical Products Inc. (NASDAQ: UTMD) has extended its tender offer to purchase up to 650,000 shares of common stock at $75.00 per share. The new deadline is Tuesday, October 27, at 5:00 p.m. New York time, allowing stockholders more time to make decisions and consider the company’s third-quarter 2026 financial results, which are scheduled for release on October 22.
Advertisement

Utah Medical Products, Inc. Extends Tender Offer

https://www.streetinsider.com/ACCESS+Newswire/Utah+Medical+Products%2C+Inc.+Extends+Tender+Offer/27146207.html
Utah Medical Products, Inc. (UTMD) has extended its tender offer to purchase up to 650,000 shares of its common stock at $75.00 per share. The new expiration date is October 27, 2026, which allows stockholders to consider the company's 3Q 2026 financial results to be announced on October 22. All other conditions of the offer remain unchanged.

The $75-a-share tender offer at Utah Medical Products (UTMD) now expires October 27, 2026.

https://www.stocktitan.net/sec-filings/UTMD/sc-to-i-a-utah-medical-products-inc-amended-issuer-tender-offer-bdf826bcfd0c.html
Utah Medical Products (UTMD) has extended its issuer tender offer expiration date from October 7, 2026, to October 27, 2026. The company is offering to repurchase up to 650,000 shares of common stock at a price of $75.00 per share. This amendment to the tender offer was filed as an SC TO-I/A with the SEC.

Utah Medical Products (UTMD) Extends Stock Buyback Offer Deadline to October 27

https://www.gurufocus.com/news/9109516/utah-medical-products-utmd-extends-stock-buyback-offer-deadline-to-october-27
Utah Medical Products (UTMD) has extended its stock buyback offer deadline to October 27, allowing shareholders more time to tender shares at $75.00 each, coinciding with its Q3 2026 earnings release. The company, a medical device manufacturer, offers a sustainable dividend yield of 1.63% and holds a strong GF Score of 73, though growth remains a weak point. While the stock is modestly overvalued, its financial stability and consistent dividend make it appealing for income-oriented investors.

Utah Medical Products, Inc. Extends Tender Offer

https://www.valuethemarkets.com/news/press-releases/utah-medical-products-inc-extends-tender-offer
Utah Medical Products, Inc. (UTMD) has extended its tender offer to purchase up to 650,000 shares of its common stock at $75.00 per share. The new expiration date is October 27, 2026, at 5:00 p.m. New York City time, allowing stockholders to consider the company's Q3 2026 financial results, which are scheduled for announcement on October 22, 2026. All other terms and conditions of the offer remain unchanged.

Utah Medical Products, Inc.'s Equity Buyback Plan Extended till October 27, 2026.

https://www.marketscreener.com/news/utah-medical-products-inc-s-equity-buyback-plan-extended-till-october-27-2026-ce785dd8db80f32c
Utah Medical Products, Inc. announced on October 5, 2026, that it has extended its equity buyback plan. The duration of the plan will now continue until October 27, 2026. This extension indicates the company's ongoing strategy regarding its share repurchase program.
Advertisement

Utah Medical Products, Inc. (UTMD) Extends $75 Tender Offer to Oct. 27

https://www.tradingview.com/news/tradingview:2743a13d5e006:0-utah-medical-products-inc-utmd-extends-75-tender-offer-to-oct-27/
Utah Medical Products, Inc. (UTMD) has extended its tender offer to purchase up to 650,000 shares at $75.00 per share until October 27, 2026. The extension provides more time for shareholders to participate, while all other terms of the offer remain unchanged. This tender offer is viewed by an AI analyst as a continuation of the company's capital return strategy, with the upcoming Q3 2026 results potentially influencing participation and stock performance.

Utah Medical Products, Inc. Extends Tender Offer

https://www.tradingview.com/news/acceswire:53d40b8ec094b:0-utah-medical-products-inc-extends-tender-offer/
Utah Medical Products, Inc. (UTMD) has extended its tender offer to purchase up to 650,000 shares of its common stock at $75.00 per share. The new expiration date is October 27, 2026, at 5:00 p.m. New York City time, allowing stockholders to consider the company's Q3 2026 financial results, which will be announced on October 22. All other terms and conditions of the offer remain unchanged.

Shareholders can consider Utah Medical’s results, scheduled for Oct. 22, before its $75 offer expires Oct. 27.

https://www.stocktitan.net/news/UTMD/utah-medical-products-inc-extends-tender-ch0r5nlwahg2.html
Utah Medical Products (Nasdaq: UTMD) has extended its tender offer to buy back up to 650,000 common shares at $75.00 each until October 27, 2026. This extension allows shareholders to review the company's third-quarter 2026 financial results, which are set to be announced on October 22. All other conditions of the tender offer remain unchanged.

Utah Medical Products, Inc. Extends Tender Offer

https://www.corsicanadailysun.com/national/utah-medical-products-inc-extends-tender-offer/article_fa84ce3d-c0bd-5b6b-bf79-3c36248c8be7.html
Utah Medical Products, Inc. (Nasdaq:UTMD) has extended its tender offer to purchase up to 650,000 shares of its common stock at $75.00 per share. The new expiration date is October 27, 2026, at 5:00 p.m. New York City time, allowing stockholders to consider the company's 3Q 2026 financial results which are expected on October 22. All other conditions of the offer remain unchanged.

Utah Medical Products, Inc. Extends Tender Offer

https://www.theglobeandmail.com/investing/markets/stocks/UTMD/pressreleases/4961091/utah-medical-products-inc-extends-tender-offer/
Utah Medical Products, Inc. (Nasdaq: UTMD) has extended its tender offer to purchase up to 650,000 shares of its common stock at $75.00 per share. The new expiration date is 5:00 p.m. New York City time, on Tuesday, October 27, to allow stockholders to consider the company's Q3 2026 financial results, which are scheduled for announcement on October 22. All other conditions of the offer remain unchanged.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement